Centro de Novos Tratamentos Itajai

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer2 trials
• Cervical cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• AstraZeneca2 trials
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

  NCT01874353· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

  NCT01844986· Phase 3· AstraZeneca· Source

Closed trials

• Completed

  Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

  NCT04646005· Phase 2· Regeneron Pharmaceuticals· Source